Each 2-fold higher level of the postoperative EGF/MCP-1 ratio was associated with a decreased risk of the composite CKD outcome after adjustment for urine creatinine (HR 0.86, 95% CI 0.81–0.92). The gene discussed is EGF; the disease is chronic kidney disease.